Found 60 matching trials
BARDA Securing Anthrax Immunity For the Elderly
PHASE2This study is designed to assess the safety and ability of BioThrax and AV7...
Location
Johnson County Clin-Trials
A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.
PHASE1This cancer vaccine research study involves the injection of the NY-ESO-1b ...
Location
Krankenhaus Nordwest
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
PHASE2Mantle cell lymphoma (MCL) is a sub-type of non-Hodgkin's lymphoma (NHL) wh...
Location
Stanford University Medical Center
Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine
PHASE1This study will evaluate the safety and immune response of healthy voluntee...
Location
Johns Hopkins University Bloomberg School of Public Health
Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine
PHASE1To evaluate the safety and tolerability of the an adjuvanted influenza vacc...
Location
Institute for Pharmacokinetic and Analytical Studies
Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7909
PHASE1This study aims to compare the safety and immunogenicity of AdCh63 AMA1 and...
Location
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Old Road, Headington
Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer
PHASE2To assess the efficacy and safety of PF-3512676 administered in combination...
Location
Pfizer Investigational Site
AMA1-C1/Alhydrogel + CpG 7909 for Malaria
PHASE1The purpose of this study is to test an experimental malaria vaccine in abo...
Location
University of Rochester
CPG 7909 in Patients Wih Stage IV Renal Cell Cancer
PHASE1CPG 7909 given alone to patients with renal cell cancer after their nephrec...
Location
Multiple Locations
Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria
PHASE1This study will evaluate the safety of an experimental vaccine can protect ...
Location
Doneguebougou Malaria Vaccine Center